Thinking Out Loud (Blog)
Meet the 6 newest EpiVax team members!
EpiVax has been busy helping our clients, and the research flywheel is spinning faster than ever. We needed more talented folks to pitch in! So far we've brought on six wonderful team members in 2021, with more to come soon! Learn more about our new folks below, and...
read more
Hope is a vaccine / L’espoir, c’est un vaccin
The news from Mali Here in Bamako, life is really not that much different from so many other countries. On the street, the average citizen is still hawking gasoline in glass bottles for 500 CFA, selling sunglasses at traffic stops, or herding goats across the road,...
read more
Vax Gives Back: Winter 2021 Activities
EpiVax is excited to provide an update on our quarterly charitable giving activities! The local non-profits featured below were selected this quarter by our EpiVax employees, as part of our efforts to support the good work of community partners around Providence,...
read more
April Newsletter: Tregitopes: What Did Nature Intend?
Tregitopes: What Did Nature Intend? Hey everybody, it's a good idea to pay attention to the forces of Nature, right? When we discovered that IgG (as in monoclonals) contained Treg epitopes (and named them “Tregitopes”) in 2008, we knew that this discovery was a big...
read more
IAVI Report Revisited: Lessons from HIV research for SARS-COV-2 vaccine design
When EpiVax CEO/CSO Annie De Groot began her decades-long focus on HIV vaccine research in the early 90’s, she couldn’t have predicted the implications for the COVID-19 pandemic…. Or perhaps she did! Interviewed by Michael Dumiak for August 2020 issue of IAVI, Annie...
read more
ConvergenceRI: Truly a Beautiful Day in the Neighborhood
Annie De Groot, CEO/CSO for EpiVax Inc, had a chance to sit down(virtually!) with Richard Asinof of CovergenceRI and Frank Casale, regional VP of TD Bank to discuss some big developments over at Clínica Esperanza. Clínica Esperanza, “Hope Clinic,” is located in the...
read more